What is the potential of using PI3K inhibitors in the management of breast cancer in the clinic

Pieter J.A. Eichhorn, Magüi Gili, Maurizio Scaltriti, Violeta Serra, Marta Guzman, Wouter Nijkamp, Roderick L. Beijersbergen, Vanesa Valero, Joan Seoane, René Bernards, José Baselga, Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235 Cancer Research. ,vol. 68, pp. 9221- 9230 ,(2008) , 10.1158/0008-5472.CAN-08-1740

Robert J. Crowder, Chanpheng Phommaly, Yu Tao, Jeremy Hoog, Jingqin Luo, Charles M. Perou, Joel S. Parker, Melinda A. Miller, David G. Huntsman, Li Lin, Jacqueline Snider, Sherri R. Davies, John A. Olson, Mark A. Watson, Anthony Saporita, Jason D. Weber, Matthew J. Ellis, PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor positive breast cancer Cancer Research. ,vol. 69, pp. 3955- 3962 ,(2009) , 10.1158/0008-5472.CAN-08-4450

Johanna C. Bendell, Jordi Rodon, Howard A. Burris, Maja de Jonge, Jaap Verweij, Diana Birle, David Demanse, Stefan S. De Buck, Qinhua C. Ru, Malte Peters, Michael Goldbrunner, José Baselga, Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors Journal of Clinical Oncology. ,vol. 30, pp. 282- 290 ,(2012) , 10.1200/JCO.2011.36.1360

Mark Pegram, Can We Circumvent Resistance To ErbB2-Targeted Agents By Targeting Novel Pathways? Clinical Breast Cancer. ,vol. 8, pp. S121- S130 ,(2008) , 10.3816/CBC.2008.S.008

José Baselga, Mario Campone, Martine Piccart, Howard A. Burris, Hope S. Rugo, Tarek Sahmoud, Shinzaburo Noguchi, Michael Gnant, Kathleen I. Pritchard, Fabienne Lebrun, J. Thaddeus Beck, Yoshinori Ito, Denise Yardley, Ines Deleu, Alejandra Perez, Thomas Bachelot, Luc Vittori, Zhiying Xu, Pabak Mukhopadhyay, David Lebwohl, Gabriel N. Hortobagyi, Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer The New England Journal of Medicine. ,vol. 366, pp. 520- 529 ,(2012) , 10.1056/NEJMOA1109653

Ingrid A. Mayer, Vandana G. Abramson, Steven J. Isakoff, Andres Forero, Justin M. Balko, María Gabriela Kuba, Melinda E. Sanders, Jeffrey T. Yap, Annick D. Van den Abbeele, Yisheng Li, Lewis C. Cantley, Eric Winer, Carlos L. Arteaga, Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide-3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 32, pp. 1202- 1209 ,(2014) , 10.1200/JCO.2013.54.0518

Donna M Muzny, Matthew N Bainbridge, Kyle Chang, Huyen H Dinh, Jennifer A Drummond, Gerald Fowler, Christie L Kovar, Lora R Lewis, Margaret B Morgan, Irene F Newsham, Jeffrey G Reid, Jireh Santibanez, Eve Shinbrot, Lisa R Trevino, Yuan-Qing Wu, Min Wang, Preethi Gunaratne, Lawrence A Donehower, Chad J Creighton, David A Wheeler, Richard A Gibbs, Michael S Lawrence, Douglas Voet, Rui Jing, Kristian Cibulskis, Andrey Sivachenko, Petar Stojanov, Aaron McKenna, Eric S Lander, Stacey Gabriel, Gad Getz, Li Ding, Robert S Fulton, Daniel C Koboldt, Todd Wylie, Jason Walker, David J Dooling, Lucinda Fulton, Kim D Delehaunty, Catrina C Fronick, Ryan Demeter, Elaine R Mardis, Richard K Wilson, Andy Chu, Hye-Jung E Chun, Andrew J Mungall, Erin Pleasance, A Gordon Robertson, Dominik Stoll, Miruna Balasundaram, Inanc Birol, Yaron SN Butterfield, Eric Chuah, Robin JN Coope, Noreen Dhalla, Ranabir Guin, Carrie Hirst, Martin Hirst, Robert A Holt, Darlene Lee, Haiyan I Li, Michael Mayo, Richard A Moore, Jacqueline E Schein, Jared R Slobodan, Angela Tam, Nina Thiessen, Richard Varhol, Thomas Zeng, Yongjun Zhao, Steven JM Jones, Marco A Marra, Adam J Bass, Alex H Ramos, Gordon Saksena, Andrew D Cherniack, Stephen E Schumacher, Barbara Tabak, Scott L Carter, Nam H Pho, Huy Nguyen, Robert C Onofrio, Andrew Crenshaw, Kristin Ardlie, Rameen Beroukhim, Wendy Winckler, Matthew Meyerson, Alexei Protopopov, Juinhua Zhang, Angela Hadjipanayis, Eunjung Lee, Ruibin Xi, Lixing Yang, Xiaojia Ren, Hailei Zhang, Narayanan Sathiamoorthy, Sachet Shukla, Peng-Chieh Chen, Psalm Haseley, Yonghong Xiao, Semin Lee, Jonathan Seidman, Lynda Chin, Peter J Park, Raju Kucherlapati, J Todd Auman, Katherine A Hoadley, Ying Du, Matthew D Wilkerson, Yan Shi, Christina Liquori, Shaowu Meng, Ling Li, Yidi J Turman, Michael D Topal, Donghui Tan, Scot Waring, Elizabeth Buda, Jesse Walsh, Corbin D Jones, Piotr A Mieczkowski, Darshan Singh, Junyuan Wu, Anisha Gulabani, Peter Dolina, Tom Bodenheimer, Alan P Hoyle, Janae V Simons, Matthew Soloway, Lisle E Mose, Stuart R Jefferys, Saianand Balu, Brian D O’Connor, Jan F Prins, Derek Y Chiang, D Neil Hayes, Charles M Perou, Toshinori Hinoue, Daniel J Weisenberger, Dennis T Maglinte, Fei Pan, Benjamin P Berman, David J Van Den Berg, Hui Shen, Timothy Triche Jr, Stephen B Baylin, Peter W Laird, Michael Noble, Doug Voet, Nils Gehlenborg, Comprehensive molecular characterization of human colon and rectal cancer Nature. ,vol. 487, pp. 330- 337 ,(2012) , 10.1038/NATURE11252

Sara A. Hurvitz, Richard J. Pietras, Rational management of endocrine resistance in breast cancer Cancer. ,vol. 113, pp. 2385- 2397 ,(2008) , 10.1002/CNCR.23875

Laura, M. Bender, Her2 cross talk and therapeutic resistance in breast cancer Frontiers in Bioscience. ,vol. Volume, pp. 3906- 3912 ,(2008) , 10.2741/2978

Pablo Rodriguez-Viciana, Patricia H. Warne, Ritu Dhand, Bart Vanhaesebroeck, Ivan Gout, Michael J. Fry, Michael D. Waterfield, Julian Downward, PHOSPHATIDYLINOSITOL-3-OH KINASE AS A DIRECT TARGET OF RAS Nature. ,vol. 370, pp. 527- 532 ,(1994) , 10.1038/370527A0